Configure Studies for FDA IND or Pre-ANDA reporting
IND Studies
Make sure to enter the clinical reference for IND studies, including the primary IND number associated with the study. Optionally, you can also add the cross-reported IND number, if applicable.
Reference Type | Country | Reference Number |
---|---|---|
CDER-IND or CBER-IND | United States | Select the Primary IND number. |
Cross reported IND | United States | Enter the cross reported IND. |
Pre-ANDA Studies
Make sure to enter the clinical reference for Pre-ANDA studies and include the primary IND number associated with the study.
Reference Type | Country | Reference Number |
---|---|---|
Pre-ANDA | United States | Enter the Pre-ANDA number. |
Note:
Cross-reported IND numbers [FDA C.5.6.r] for IND reports are auto-populated by Interchange based on the product's license configuration. Refer to the FAERS mappings in the E2B R3 mapping document for additional details. Additionally, manually configured INDs in the study will also be transmitted.
Parent topic: Set up reporting destinations to send E2B(R3) report